OAKVILLE, Ontario – June 8, 2015 – Takeda Canada commends Crohn’s and Colitis Canada for the success of the group’s 20th annual fundraising Gutsy Walk for Crohn’s and Colitis. This year’s event was held on Sunday, June 7, at 60 locations across Canada and the goal for this year is to raise more than $3 million.
Teams of walkers and individuals of all ages collect donations and pledges and gather for a fun-filled walk that raises much-needed funds. The annual event also provides those affected with Crohn’s disease and ulcerative colitis an opportunity to meet and get to know each other while collectively supporting an important cause.
Along with marking the 20th anniversary of the successful and still-growing annual event, this year’s walk was the occasion for the launch of the most ambitious fundraising campaign ever by Crohn’s and Colitis Canada – a drive to raise $100 million for transformational research, education and advocacy. The campaign is called “Crohn’s and Colitis – Make it Stop. For Life.” The goal is for every child and adult with these diseases to live life to the fullest and ultimately to be cured.
“Takeda Canada is proud to be associated with the Gutsy Walk for Crohn’s and Colitis as one of the event’s national sponsors. It’s an important event for the organization and Takeda recognizes this which is why we encourage volunteer participation of our employees,” said Mike Egli, President of Takeda Canada Inc. “We congratulate everyone who organized and took part in this worthy cause. Crohn’s disease and colitis take a big toll on patients and their families, so Takeda Canada is very pleased to help raise awareness by supporting this cross-Canada effort.”
About Crohn’s & Colitis Canada
Crohn’s and Colitis Canada is a volunteer‐based registered charity that is dedicated to finding the cures for Crohn’s disease and ulcerative colitis and to improving the lives of children and adults affected by these chronic diseases. Crohn’s and Colitis Canada provides education, advocacy and awareness activities across Canada to people living with these diseases, their families, healthcare professionals and the general public.
Crohn’s and Colitis Canada is uniquely positioned to stop these diseases. The organization is at the core of inflammatory bowel disease research in Canada and is a powerhouse on the world stage. To date, Crohn’s and Colitis Canada has invested over $88 million in major research projects and is Canada’s largest non‐governmental funder of Crohn’s and colitis research. To learn more, visit: www.crohnsandcolitis.ca.
About Takeda Canada
Takeda Canada, located in Oakville, Ontario, is the Canadian sales and marketing organization of Takeda Pharmaceutical Company Limited, Osaka, Japan. The company has a commercial presence covering more than 70 countries, with particular strength in Asia, North America, Europe and fast-growing emerging markets including Latin America, Russia-CIS and China. Areas of focus include cardiovascular and metabolic, oncology, respiratory and immunology, central nervous system, general medicine, and vaccines.
Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Through strategic acquisitions, Takeda has been transforming itself, broadening its therapeutic expertise and geographic outreach.
Additional information about Takeda Canada is available through its website: www.takedacanada.com